Biolake hosts major investment signing ceremony for Q2 projects
The signing ceremony for key second-quarter investment projects in Biolake. [Photo/WeChat account of Optics Valley of China]
On June 18, the China Organoids and Organ Chips Industry Summit Forum and the Optics Valley Biolake Investment Promotion Conference were held in the East Lake High-tech Development Zone (also known as Optics Valley of China, or OVC).
The event attracted over 200 experts, scholars, entrepreneurs, and investors in the field of biology. During the conference, a signing ceremony for key second-quarter investment projects in Biolake was held, with a total contract value of 7.69 billion yuan ($1.08 billion). The nation's first Organoids and Organ Chips Industry Innovation Alliance was also established.
Nine representative companies signed agreements to set up operations in the area, focusing on fields such as innovative drugs, high-end medical devices, precision diagnostics and treatment, synthetic biology, and medical aesthetics and health.
During the conference, Biolake and the China (Hubei) Pilot Free Trade Zone Wuhan Area Branch of Shanghai Pudong Development Bank signed a strategic cooperation agreement. In the future, the branch will provide comprehensive financial services to park enterprises, greatly empowering the innovative development of biology companies.
After 15 years of development, the life and health industry in OVC has cultivated 484 high-tech enterprises, seven listed companies, and three leading enterprises with a market value exceeding 10 billion yuan.
